4,652
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Targeting of stabilized plasmid lipid particles to hepatocytes in vivo by means of coupled lactoferrin

, , , , , & show all
Pages 585-594 | Received 18 Mar 2007, Accepted 11 Jun 2007, Published online: 08 Oct 2008

References

  • Andersen JH, Osbakk SA, Vorland LH, Traavik T, Gutteberg TJ. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 2001; 51: 141–149
  • Armeanu S, Lauer UM, Smirnow I, Schenk M, Weiss TS, Gregor M, Bitzer M. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res 2003; 63: 2369–2372
  • Bartsch M, Weeke-Klimp AH, Meijer DKF, Scherphof GL, Kamps JAAM. Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells. Pharm Res 2002; 19: 676–680
  • Beljaars L, Bakker HI, Van der Strate BW, Smit C, Duijvestijn AM, Meijer DKF, Molema G. The antiviral protein human lactoferrin is distributed in the body to cytomegalovirus (CMV) infection-prone cells and tissues. Pharm Res 2002; 19: 54–62
  • Bijsterbosch MK, Ziere GJ, Van Berkel TJ. Lactosylated low density lipoprotein: A potential carrier for the site-specific delivery of drugs to Kupffer cells. Mol Pharmacol 1989; 36: 484–489
  • Böttcher CJF, Van Gent CM, Pries C. A rapid and sensitive sub-micro phosphorus determination. Anal Chim Acta 1961; 24: 204–205
  • Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch Biochem Biophys 1998; 357: 185–194
  • Brunner S, Sauer T, Carotta S, Cotten M, Saltik M, Wagner E. Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther 2000; 7: 401–407
  • Casteleijn E, Van Rooij HC, Van Berkel TJ, Koster JF. Mechanism of glucagon stimulation of fructose-1,6-bisphosphatase in rat hepatocytes. Involvement of a low-Mr activator. FEBS Lett 1986; 201: 193–197
  • Chen T, Palmer LR, Fenske DB, Lam AMI, Wong KF, Cullis PR. Distal cationic poly(ethylene glycol) lipid conjugates in large unilamellar vesicles prepared by extrusion enhance liposomal cellular uptake. J Liposome Res 2004; 14: 155–173
  • Choi JS, MacKay JA, Szoka FC, Jr. Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: Preparation and characterization. Bioconjug Chem 2003; 14: 420–429
  • Daemen T, Veninga A, Roerdink FH, Scherphof GL. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res 1986; 46: 4330–4335
  • Derksen JTP, Scherphof GL. An improved method for the covalent coupling of proteins to liposomes. Biochim Biophys Acta 1985; 814: 151
  • El Yazidi-Belkoura I, Legrand D, Nuijens J, Slomianny MC, van Berkel P, Spik G. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus. Biochim Biophys Acta 2001; 1568: 197–204
  • George JA, St. Gene therapy progress and prospects: Adenoviral vectors. Gene Ther 2003; 10: 1135–1141
  • He J, Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 1995; 373: 721–724
  • Hofland HE, Shephard L, Sullivan SM. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc Natl Acad Sci USA 1996; 93: 7305–7309
  • Hofland HE, Masson C, Iginla S, Osetinsky I, Reddy JA, Leamon CP, Scherman D, Bessodes M, Wils P. Folate-targeted gene transfer in vivo. Mol Ther 2002; 5: 739–744
  • Imber MJ, Pizzo SV, Johnson WJ, Adams DO. Selective diminution of the binding of mannose by murine macrophages in the late stages of activation. J Biol Chem 1982; 257: 5129–5135
  • Ishida E, Managit C, Kawakami S, Nishikawa M, Yamashita F, Hashida M. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice. Pharm Res 2004; 21: 932–939
  • Ismail M, Brock JH. Binding of lactoferrin and transferrin to the human promonocytic cell line U937. Effect on iron uptake and release. J Biol Chem 1993; 268: 21618–21625
  • Kamps JAAM, Swart PJ, Morselt HW, Pauwels R, De Bethune MP, De Clercq E, Meijer DKF, Scherphof GL. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: Drug carriers with an intrinsic anti-HIV activity. Biochim Biophys Acta 1996; 1278: 183–190
  • Keidar S, Kaplan M, Aviram M. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Arterioscler Thromb Vasc Biol 1996; 16: 97–105
  • Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481–8487
  • Mazurier J, Legrand D, Hu WL, Montreuil J, Spik G. Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur J Biochem 1989; 179: 481–487
  • Monck MA, Mori A, Lee D, Tam P, Wheeler JJ, Cullis PR, Scherrer P. Stabilized plasmid-lipid particles: Pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. J Drug Target 2000; 7: 439–452
  • Muller K, Nahde T, Fahr A, Muller R, Brusselbach S. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles. Cancer Gene Ther 2001; 8: 107–117
  • Nozaki A, Ikeda M, Naganuma A, Nakamura T, Inudoh M, Tanaka K, Kato N. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J Biol Chem 2003; 278: 10162–10173
  • Nuijens JH, van Berkel PH, Schanbacher FL. Structure and biological actions of lactoferrin. J Mammary Gland Biol Neoplasia 1996; 1: 285–295
  • Palmer LR, Chen T, Lam AMI, Fenske DB, Wong KF, MacLachlan I, Cullis PR. Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. Biochim Biophys Acta 2003; 1611: 204–216
  • Peen E, Johansson A, Engquist M, Skogh T. Hepatic and extrahepatic clearance of circulating human lactoferrin: An experimental study in rat. Eur J Haematol 1998; 61: 151–159
  • Penco S, Scarfi S, Giovine M, Damonte G, Millo E, Villaggio B, Passalacqua M, Pozzolini M, Garre C, Benatti U. Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 2001; 34: 151–159
  • Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977; 83: 346–356
  • Reddy JA, Abburi C, Hofland H, Howard SJ, Vlahov I, Wils P, Leamon CP. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther 2002; 9: 1542–1550
  • Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 1995; 270: 16221–16224
  • Rudolph C, Plank C, Lausier J, Schillinger U, Muller RH, Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003; 278: 11411–11418
  • Sandhu AP, Lam AMI, Fenske DB, Palmer LR, Johnston M, Cullis PR. Calcium enhances the transfection potency of stabilized plasmid-lipid particles. Anal Biochem 2005; 341: 156–164
  • Saravolac EG, Ludkovski O, Skirrow R, Ossanlou M, Zhang YP, Giesbrecht C, Thompson J, Thomas S, Stark H, Cullis PR, Scherrer P. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity. J Drug Target 2000; 7: 423–437
  • Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 1992; 267: 14987–14997
  • Shi N, Pardridge WM. Noninvasive gene targeting to the brain. Proc Natl Acad Sci USA 2000; 97: 7567–7572
  • Shi N, Zhang Y, Zhu C, Boado RJ, Pardridge WM. Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci USA 2001; 98: 12754–12759
  • Ulvatne H, Haukland HH, Olsvik O, Vorland LH. Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett 2001; 492: 62–65
  • Van Berkel PH, Geerts ME, van Veen HA, Mericskay M, de Boer HA, Nuijens JH. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J 1997; 328(Pt 1)145–151
  • Van Dijk MCM, Ziere GJ, van Berkel TJC. Characterization of the chylomicron (remnant) recognition sites on parenchymal and Kupffer cells of rat liver: Selective inhibition of parenchymal cell recognition by lactoferrin. Eur J Biochem 1992; 205: 775–784
  • Wheeler JJ, Palmer L, Ossanlou M, MacLachlan I, Graham RW, Zhang YP, Hope MJ, Scherrer P, Cullis PR. Stabilized plasmid-lipid particles: Construction and characterization. Gene Ther 1999; 6: 271–281
  • Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res 1970; 31: 125–150
  • Wu J, Liu P, Zhu L, Maddukuri S, Zern MA. Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents. Hepatology 1998; 27: 772–778
  • Xu L, Pirollo KF, Tang WH, Rait A, Chang EH. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 1999; 10: 2941–2952
  • Xu L, Huang CC, Huang W, Tang WH, Rait A, Yin YZ, Cruz I, Xiang LM, Pirollo KF, Chang EH. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 2002; 1: 337–346
  • Ziere GJ, van Dijk MC, Bijsterbosch MK, Van Berkel TJ. Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem 1992; 267: 11229–11235
  • Ziere GJ, Kruijt JK, Bijsterbosch MK, Van Berkel TJ. Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: Involvement of proteoglycans and the remnant receptor. Biochem J 1996; 313(Pt 1)289–295

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.